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The mechanism of selective albuminuria in minimal change
nephrotic syndrome, in which glomerular capillaries are
diffusely covered by effaced podocyte foot processes with
reduced slit diaphragms, is unknown. Podocyte injury is due,
in part, to NADPH-induced oxidative stress. Here we
studied mechanism of selective albuminuria in puromycin
aminonucleoside (PAN) nephrotic rats, a model of minimal
change nephrotic syndrome. In these rats, Evans Blue-labeled
human albumin was taken up by podocytes and its urinary
excretion markedly increased, with retained selectivity for
albumin. Immunogold scanning electron micrographic
images found increased human albumin in podocyte vesicles
and on the apical membrane in nephrotic compared with
control rats. Apocynin, an inhibitor of NADPH oxidase,
decreased superoxide production in podocytes, and inhibited
endocytosis and urinary albumin excretion. Real-time
confocal microscopy found an initial delay in the appearance
of Evans Blue-labeled human albumin in the tubular lumen,
reflecting the time needed for transcellular transport.
Immunoprecipitation analysis indicated that FcRn, a receptor
for albumin transport, mediated podocyte albumin transport,
and treatment with anti-FcRn antibody reduced proteinuria
in these nephrotic rats. Thus, podocyte albumin transport
was enhanced in PAN nephrotic rats by means of FcRn, which
may explain the mechanism of selective proteinuria. This was
blocked by apocynin, suggesting a new therapeutic
approach.
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The mechanism of proteinuria in minimal change nephrotic
syndrome (MCNS) remains a mystery. In particular, it is
unclear why such large amounts of protein can leak from the
glomerular capillaries, which are diffusely covered by effaced
foot processes, and how selectivity for albumin is retained
when slit pores are assumed to be morphologically damaged
because of reduced nephrin expression.
It is generally accepted today that the slit diaphragm is the
main filtration barrier for proteins, whereas the glomerular
basement membrane (GBM) is a coarse pre-filter.1 However,
in the past, there has been considerable controversy over
which component of the glomerulus is the most important
barrier, since the slit diaphragm was identified in 1955.2
Farquhar et al.3,4 stated it was the GBM, based on studies
using ferritin and dextran, for these tracers accumulated
on the luminal surface of the GBM, but not under the slit
diaphragm. The ‘GBM theory’ was also supported by the
concept of the charge barrier.5 Recently, laminin-b2-deficient
mice were shown to develop proteinuria, creating renewed
interest in the GBM.6 By contrast, Karnovsky et al.7 proposed
the ‘slit diaphragm theory’ in a study demonstrating the
‘zipper structure’ with slit pores identical in size to albumin.
He also conducted tracer studies with horseradish peroxidase
(HRP), myeloperoxidase, and catalase, and found immuno-
histochemical staining at the slit diaphragm.8,9 Identification
of slit diaphragm proteins such as nephrin, the mutations
of which cause proteinuria, has further strengthened this
theory.10,11 Thus, today it is generally believed that protein
molecules are filtered through the slit diaphragm, and in
nephrotic states, protein is assumed to leak from enlarged slit
pores because of decreased nephrin expression.
However, in MCNS, podocyte slits are markedly reduced
with a tight junction-like alteration,12 and we did not observe
glomerular albumin filtered through the slit diaphragm using
8 nm gold- or fluorescein isothiocyanate-labeled albumin in
puromycin aminonucleoside (PAN) nephrosis, a representa-
tive MCNS model.13 The limitations of the study were that
free fluorescein isothiocyanate cannot be completely removed
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even after intensive dialysis, and thus may have influenced
the results, and that 8 nm gold-labeled albumin is too large to
pass through the slit pores. To solve these limitations, in the
present study we used human serum albumin labeled with
Evans Blue (EB), which strongly and specifically binds to
albumin without altering the molecular weight or shape of
albumin due to its small size (961 kDa).14 We have attempted
to visualize three dimensionally the glomerular transport
pathways of EB-labeled human serum albumin in a rat MCNS
model using immunogold scanning electron microscope
(SEM), and also investigated the time course of albumin
transport using green fluorescent protein (GFP) transgenic
rats. Moreover, as oxidative stress via NADPH oxidase is
involved in podocyte injury,15 we have verified the effects of its
inhibitor, apocynin, on podocyte albumin handling. As a
mechanism of selective albuminuria in MCNS, we hypothe-
sized the existence of specific receptors for albumin transport
in podocytes, and we tested antibodies against FcRn, which
is one of the receptors for albumin transport.16,17
RESULTS
Podocyte uptake and urinary excretion of EB-labeled
human serum albumin
First, we tried to visualize glomerular albumin transport by
using EB-labeled human serum albumin as a tracer, which is
detectable by both light and fluorescence microscopy, and
quantifiable by spectrophotometry. EB specifically binds to
albumin, with minimal free EB (o0.001%) in the super-
natant after precipitation by trichloroacetic acid. We also
verified by gel electrophoresis that EB does not alter the
charge of albumin, for the migration distance by charge was
identical between EB-labeled human serum albumin and
unlabeled albumin, which has an isoelectric point of 4.9.18
Light micrographs after 90min of EB-labeled human serum
albumin injection showed that EB-labeled albumin uptake
was markedly increased in both glomerular cells and
proximal tubule cells in PAN nephrotic rats, whereas it was
absent in glomeruli with slight uptake in proximal tubule
cells in controls (Figure 1a and b). Confocal microscopic
observation of EB fluorescence also confirmed increased
EB-labeled albumin uptake by these cells in PAN nephrosis,
but not in the control (Figure 1c and d). Podocyte uptake
showed some heterogeneity among podocytes. Western
blotting using microdissected glomeruli showed that
glomerular uptake of EB-labeled human serum albumin
was increased in PAN rats (Figure 2b). In accordance with
these findings, clearance studies showed a 132-fold increase
in 24 h urinary EB-labeled human serum albumin excretion
in PAN nephrotic rats compared with controls (Figure 2a).
SDS-PAGE of urine confirmed that proteinuria was highly
selective for albumin (Figure 2c and d).
Albumin passage through the glomerulus visualized by
immunogold TEM and SEM
By observation at subcellular levels with immunogold
transmission electron microscopy (TEM) and SEM, we
found numerous gold particles labeling human serum
albumin located inside cytoplasmic vesicles in images of
podocyte cross-sections in PAN rats (Figures 3b and 4d),
whereas they scarcely existed in podocytes of controls
(Figures 3a and 4c), suggesting increased podocyte endocy-
tosis in PAN nephrosis. Immunogold TEM images also
showed gold particles, indicating human albumin localized
on apical membranous protrusions and microvilli (Figure 3c
and d), and albumin-including vesicles just about to be
excreted from the apical membrane (Figure 3e). SEM
observation confirmed these results, and gold particles
labeling human serum albumin on the surface of podocytes
were increased in PAN nephrotic rats compared with controls
(Figure 4a and b). Moreover, observation at higher
magnification in the secondary electron mode revealed
multiple granular protrusions on the podocyte surface,
suggesting shedding vesicles in PAN nephrosis (Figure 4e
and f). These results suggested that albumin passes through
the podocyte cell body and is excreted into the urinary space
in nephrotic conditions.
Increased reactive oxygen species production in
podocytes in PAN nephrosis
Reactive oxygen species (ROS) produced by NADPH oxidase
are presumed to cause podocyte injury in PAN nephrosis.
We detected the NADPH oxidase component p47phox
staining on the podocyte plasma membrane and cytoplasmic
vesicles by immunocytochemistry in PAN rats, but not in
controls (Figure 5a). Superoxide production detected by
Control PAN
Figure 1 |Renal uptake of injected Evans Blue (EB)-labeled
human serum albumin is increased in puromycin
aminonucleoside (PAN) nephrotic rats. Images of kidneys after
continuous injection for 90min in controls (a, c) and PAN
nephrotic rats (b, d). (a, b) Light micrographs of vibratome sections
of rat kidneys. (c, d) Confocal images showing localization of EB-
labeled human serum albumin in 5mm Lowicryl sections. Uptake
of EB-labeled human serum albumin was markedly increased in
podocytes and proximal tubular cells. The degree of uptake was
heterogenous among podocytes. Bar¼ 50mm.
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cerium chloride histochemistry was observed on the
plasma membrane of podocytes, the GBM, and endothelial
cells on day 2 after PAN injection, whereas it was almost
negative in controls (Figure 5c). Urinary H2O2 excretion
peaked on day 2, preceding proteinuria or foot process
effacement, and returned to baseline at day 7 when
proteinuria peaked with full-fledged foot process effacement
(Figure 5b).
The effect of NADPH oxidase inhibition by apocynin on
podocyte albumin transport
We examined the effects of NADPH oxidase inhibition by
apocynin, derived from the medicinal herb Picrorhiza kurroa,
and found that apocynin treatment significantly suppressed
urinary H2O2 excretion, 24 h urinary EB-labeled human
serum albumin excretion, and proteinuria in PAN nephrotic
rats (Figures 2a and 5b). Foot process effacement was partly
restored with apocynin treatment (Figure 6b), and immu-
nogold particles for EB-labeled human serum albumin in
podocyte vesicles, cytoplasm, and cell surface in PAN
nephrotic rats were significantly decreased with apocynin
treatment (Figure 6), suggesting that apocynin inhibits
albumin endocytosis and shedding excretion.
In vivo real-time observation of EB-labeled human
serum albumin in GFP transgenic rats
To elucidate the time course of glomerular albumin
transport, we observed kidneys of GFP transgenic rats after
EB-labeled human serum albumin injection with real-time
confocal microscopy. The red fluorescence of EB was absent
in the proximal tubular lumen until 5min after injection, and
increased at 15min in PAN rats, whereas it was almost
negative in controls (Figure 7a), indicating that a large
proportion of albumin is slowly transported through
podocytes. In vibratome sections of kidney, the cytoplasm
of some podocytes appeared yellow in PAN nephrotic
rats, due to merging of the green fluorescent signals of
GFP and the red fluorescence of EB, which was not observed
in controls (Figure 7b). The degree of EB-labeled
human serum albumin uptake by podocytes was hetero-
genous among cells. These results further reinforced the
hypothesis that albumin is transported through the podocyte
cytoplasm.
The role of FcRn in albumin transportation
As FcRn has been reported as an albumin and immuno-
globulin (Ig)G receptor known to be expressed on podocytes,16
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Figure 2 |Twenty-four hours renal clearance study after a single injection of Evans Blue-labeled human serum albumin (EB-HSA) in
controls, nephrotic rats induced by puromycin aminonuculeoside (PAN) at 5 days, and PAN rats treated with apocynin starting
2 days before PAN injection (PANþ apocynin). (a) Measurement of 24 h urinary EB-labeled human serum albumin excretion and
proteinuria. Data are shown as mean±s.e.m. **Po0.01 versus control. zPo0.05, zzPo0.01 versus PAN. (b) Western blotting for human
serum albumin of microdissected glomeruli. Uptake of albumin by glomerular cells was increased in PAN nephrotic rats. (c) SDS-PAGE for
urine. (d) Densitometry was performed to calculate the urinary IgG/albumin ratio, in order to compare the selectivity of urinary proteins.
Each group includes five rats. Cr, creatinine.
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we demonstrated by immunoprecipitation that human serum
albumin bound to FcRn was increased in podocytes of PAN
nephrotic rats, which decreased by apocynin treatment,
suggesting that FcRn has a role in albumin transport
(Figure 8a). To further confirm this, we treated PAN
nephrotic rats with antibody against rat FcRn, which resulted
in reduced proteinuria and suppressed uptake of EB-labeled
human serum albumin in podocytes compared with
untreated PAN nephrotic rats (Figure 8b–d).
DISCUSSION
The novel findings in this study are the presence of albumin
endocytosis and excretion by podocytes in a MCNS animal
model, and that the albumin receptor FcRn mediates this
process. We have also shown that the NADPH oxidase
inhibitor, apocynin, effectively suppressed this process and
ameliorated proteinuria.
The most commonly accepted hypothesis of proteinuria in
MCNS is that proteins leak from the slit pores with reduced
nephrin expression.19,20 However, it seems difficult to explain
both massive proteinuria and selective albuminuria by
reduction of nephrin leading to enlarged slit pores. Actually,
in rats with a heterozygous defect in the nephrin gene,
proteinuria was absent.21 In addition, in nephrosis induced
by nephrin antibodies, nephrin expression was lowest after
1 h, before proteinuria appeared, and proteinuria decreased
at 2 weeks, when nephrin expression remained sup-
pressed.22,23 These findings raise doubts as to whether nephrin
deficiency is a cause of proteinuria. It is possible that reduced
nephrin expression in nephrotic syndromes is merely a
reflection of the decrease in slit number.24,25 Loss of the
charge barrier is another hypothesis, but previous
studies have shown that this alone is not sufficient to cause
nephrosis.5,26 Podocyte detachment or GBM rupturing causes
nonselective proteinuria,27,28 but they are usually absent in
human MCNS and low-dose PAN nephrosis used in the
present study. Thus, previous theories do not decisively
explain the pathophysiology of selective proteinuria in MCNS.
We have confirmed in this study that PAN nephrosis
presents with selective proteinuria; the selectivity of protei-
nuria evaluated by the urinary IgG/albumin ratio
was comparable between PAN nephrotic rats and controls
(Figure 2c and d). We made use of EB-labeled human serum
albumin as a tracer to elucidate the mechanism of selective
albuminuria, and results indeed suggested enhanced albumin
endocytosis in nephrotic podocytes. Podocyte vesicles have
often been observed in TEM studies of nephrotic syndrome
kidneys, but their significance has been unclear.29–33 Our
immunogold TEM and SEM studies demonstrated that
labeled albumin was taken up in these vesicles (Figures 3b
and 4d). Considerable heterogeneity was observed among
podocytes in the degree of human serum albumin uptake in
GBM
GBM
GBMGBM
GBM
Figure 3 | Immunogold transmission electron microscopy (TEM) images labeling for Evans Blue-labeled human serum albumin in
the podocytes. In the control (a), there were hardly any immunogold particles in podocytes. Many gold particles were present in podocyte
vesicles (b), apical protrusions (c), microvilli (d), and vesicles just about to be excreted from the apical membrane (e) in puromycin
aminonuculeoside (PAN) nephrotic rats. GBM, glomerular basement membrane. Bar¼ 100 nm.
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PAN nephrotic rats, which is also proven by the large
standard error value of the number of immunogold particles
for EB-labeled human albumin in Figure 6g. However, this is
consistent with a recent report that demonstrates focally high
permeability for proteins around some podocytes in the PAN
nephrotic model.34 Recently, Eyre et al.35 demonstrated that
albumin is taken up in endosomes of cultured human
podocytes. Uptake was specific for albumin, suggesting a
receptor-mediated process. In addition, a SEM study
observing the podocyte basolateral membrane, after removal
of the GBM, revealed markedly increased coated pits in PAN
nephrosis, suggesting enhanced endocytosis.36 In our study,
many albumin molecules were observed on the podocyte
apical surface in PAN nephrosis by immunogold SEM
(Figure 4b), implying excretion from the apical membrane.
Numerous protrusions resembling shedding vesicles were
observed in the SE mode (Figure 4f), which is consistent with
the excretory pathway recently demonstrated in the kid-
ney.37,38 Thus, we hypothesized that podocytes may transport
albumin by means of endocytosis and excretion by shedding
in PAN rats.
Can podocytes actually transport such massive amounts of
albumin? In the study by Eyre et al.,35 the maximal rate of
endocytosis was shown to be 97.4 mg/mg cell protein/h.
Human glomeruli contain 878±220 podocytes,39 a human
kidney contains approximately 106 glomeruli, and protein
accounts for 21% of the total cell weight; thus, if the
podocyte is represented as a sphere with a radius of 10 mm,
the estimated total endocytic capacity in human kidneys will
be 3.6 g/day [97.4 mg/mg cell protein/h 0.21mg cell protein/
mg cell 43 p (10 mm)3 878 cells per glomerulus 2 106
glomeruli per kidney 24 h]. This indicates that podocytes
are capable of transporting nephrotic levels of protein, at least
in vitro.
The mechanism of albumin-specific endocytosis has been
established in other epithelial and endothelial cells, mediated
by receptors such as megalin and gp60.40–42 We have
demonstrated that there is a marked increase in FcRn
binding of albumin in podocytes of PAN nephrotic rats
(Figure 8a), and treatment with an antibody against FcRn
partially inhibited proteinuria and podocyte albumin uptake
in the PAN nephrotic rats. FcRn may mediate podocyte
albumin transport in MCNS, which may be the mechanism
underlying selective albuminuria in this disease. The true
roles of FcRn in podocytes are yet to be ascertained, and
further studies are necessary.
A further important finding in our study is that it took
more than 5min after injection of labeled albumin before it is
steadily excreted into the proximal tubular lumen (Figure
7a). This indicates that increased albumin excretion in
MCNS is not mainly due to slit diaphragm dysfunction,
because, if it is so, albumin filtration should be maximal soon
after injection when plasma concentration is highest.
This initial delay in excretion may reflect a period when
albumin is transported through podocytes by endocytosis
and shedding excretion.
The mechanism of podocyte dysfunction in PAN
nephrosis is not understood in detail, but ROS overproduc-
tion is said to cause cytoskeletal changes such as actin
disaggregation, resulting in foot process effacement and
podocyte deformity.43 We have shown that NADPH oxidase
expression and superoxide production were increased in
podocytes in PAN nephrosis before proteinuria appeared
(Figure 5), suggesting that ROS may be a trigger leading to
podocyte deformity and enhanced endocytosis. We have
previously demonstrated that apocynin inhibits NADPH
oxidase by preventing assembly of the p47phox and p67phox
subunits within the membrane NADPH oxidase complex,
and reduces albuminuria in diabetic nephropathy.44 In this
study, apocynin reduced podocyte superoxide production,
partially restored foot processes, suppressed endocytosis via
FcRn and shedding excretion of EB-labeled human serum
albumin in podocytes, and reduced proteinuria (Figure 2, 5, 6).
Increased podocyte vesicles containing albumin have also been
observed in diabetic rats, and apocynin has been reported to
P
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Control PAN
Figure 4 |Podocyte albumin transport as visualized by
immunogold scanning electron microscope (SEM). (a–d)
Immunogold SEM against human serum albumin after 90min of
injection in controls (a, c) and puromycin aminonucleoside (PAN)
nephrotic rats (b, d). Many gold particles are present in
cytoplasmic vesicles and on the cell surface of podocytes in PAN
nephrotic rats. (e, f) Secondary electron images of the podocyte
surface at high magnification. Many granular protrusions are seen
on the podocyte surface in PAN nephrotic rats (f), whereas these
are absent in controls (e). C, glomerular capillary; P, podocyte; U,
urinary space; V, vesicle. Each group includes four rats.
Bars¼ 1 mm (a–d), 500 nm (e, f).
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reduce podocyte ROS and proteinuria in this condition.30,44
On the basis of these observations, apocynin may inhibit
albumin endocytosis in podocytes and may be a promising
potential therapeutic drug for diseases presenting with selective
proteinuria.
The limitations of this study are that we could not use
two-photon excitation microscopy, which enables higher-
quality imaging, and that we could not observe the
glomerulus directly. However, our observation is consistent
with the results of Russo et al.,45 which visualize glomerular
transport of Alexa 568-labeled albumin using two-photon
microscopy. They demonstrated that labeled albumin was
observed weakly in the proximal tubular lumen 40 s after
injection and increased after 14min in PAN nephrotic rats.
As it is difficult to remove free Alexa 568 (MW 792) completely
even by dialysis, fluorescence at 40 s may have been caused by
free Alexa 568 filtered through the slit diaphragm. It is also
possible that albumin uptake by podocytes may not be a main
mechanism of albuminuria in MCNS, but a side phenomenon
occurring in the podocytes surrounded by abundant protein in
Bowman’s space. Even if this is true, it is still important because
albumin uptaken by podocytes may cause increased ROS
production and podocyte damage, resulting in podocyte loss or
apoptosis, and lead to massive proteinuria.46,47 Finally, in this
study, apocynin was administrated preventively, and therefore
we have not verified whether the drug possesses a therapeutic
effect when given after the onset of nephrotic syndrome.
In conclusion, EB-labeled human albumin was filtered
only in trace amounts in controls, whereas in the minimal
change nephrotic syndrome model, enhanced podocyte
endocytosis of labeled albumin, mediated by FcRn, and
excretion from the podocyte cell surface was observed, which
resulted in selective albuminuria.
ROS overproduction by NADPH oxidase has a role in the
disease pathogenesis, and inhibition with apocynin
suppressed podocyte albumin endocytosis and excretion,
and ameliorated proteinuria, shedding light on apocynin as a
new therapeutic approach.
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Figure 5 |Reactive oxygen species (ROS) production by NADPH oxidase in controls, puromycin aminonucleoside (PAN) nephrotic
rats, and PAN rats treated with apocynin (PANþ apocynin). (a) Light micrographs (top, toluidine blue staining) and electron
micrographs (bottom) of Lowicryl sections prepared for pre-embedding immunoelectron microscopy for the NADPH oxidase subunit
p47phox. The inset shows an enlargement of the podocytes stained for p47phox. (b) Measurement of urinary hydrogen peroxide (H2O2)
levels and proteinuria. **Po0.01 versus control; þPo0.05, þ þPo0.01 versus PAN-2d; #Po0.05, ##Po0.01 versus PAN-7d, $$Po0.01 versus
PAN-7d, zPo0.05 versus PANþ apocynin. (c) Detection of ROS by cerium chloride histochemistry. Cerium chloride precipitation indicating
superoxide production was observed on the plasma membrane of podocytes, the glomerular basement membrane, and endothelial cells on
day 2 after puromycin injection in PAN nephrotic rats, which decreased with treatment by apocynin. Each group includes four to eight rats.
Bars¼ 50 mm (a, top), 200 nm (a, bottom), and 500 nm (c). BW, body weight; Cr, creatinine.
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MATERIALS AND METHODS
Animals and experimental designs
Male Sprague–Dawley rats (Charles River Laboratories, Shizuoka,
Japan) weighing 110–130 g, housed in a temperature- and humidity-
controlled room with access to tap water and standard animal chow,
were used as controls (n¼ 11), and nephrotic syndrome was
induced by intraperitoneal administration of PAN (15mg/100 g
body weight; Sigma Chemical, St Louis, MO, n¼ 17). Five days later,
nephrotic syndrome was confirmed by measurement of urinary
protein. For in vivo confocal microscopy, GFP transgenic rats (Lewis
transgenic rats; a generous gift from PhoenixBio, Tochigi, Japan)
that ubiquitously express enhanced GFP were used.48 Some PAN
nephrotic rats were continuously treated with apocynin (4-hydroxy-
3-methoxyacetophenone, 16mg/kg/day in drinking water; Avocado
Research Chemicals, Heysham, UK, n¼ 8), starting 2 days before
PAN administration. As described later, six male Sprague–Dawley
rats weighing 60–100 g were used for the study of the treatment with
antibody against rat FcRn. Animals were anesthetized with
pentobarbital (50mg/kg body weight). All procedures were
conducted in accordance with the Guide for Animal Experimenta-
tion of the Faculty of Medicine, The University of Tokyo (Tokyo,
Japan), and the NIH Guide for the Care and Use of Laboratory
Animals. This study has been approved by the Medical Experimental
Animal Ethics Committee of the University of Tokyo (approval
number P10-079).
Glomerular transport of EB-labeled human serum albumin
EB was added to 4% human serum albumin in sterile physiological
saline at a 3:1 molecular ratio. EB-labeled human serum albumin
was continuously infused at 1ml/h for 90min following 1ml
injection through a jugular vein catheter. Kidneys were fixed with
either 2.5% glutaraldehyde and 2% paraformaldehyde in 0.01 M
phosphate-buffered saline or periodate-lysine-paraformaldehyde
solution and embedded in epoxy resin and Lowicryl (Electron
Microscopy Sciences, Washington, PA), respectively. Slices (100 mm)
cut by vibratome (Dosaka EM, Kyoto, Japan) were observed by light
microscopy. Lowicryl sections (5 mm) were also observed with
excitation at 568 nm, laser power at 30mW, and 599ms exposure
time to detect EB fluorescence in podocytes.
In vivo visualization of podocyte EB-labeled human serum
albumin uptake and excretion by confocal microscopy
Two GFP rats in which PAN nephrosis was induced and one control
GFP rat were anesthetized, then the left kidney was placed in a
kidney cup, and observed under a real-time confocal scanner
unit CSU-21 (Yokogawa Electric Corporation, Tokyo, Japan). After
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Figure 6 | Effect of apocynin on endocytosis and excretion of Evans Blue (EB)-labeled human serum albumin. (a–f) Observation by
immunogold transmission electron microscopy (TEM) (a, b) and scanning electron microscope (SEM) (c–f) methods in puromycin
aminonucleoside (PAN) nephrotic rats untreated (n¼ 8, a, c, e), or treated with apocynin (PANþ apocynin, n¼ 5, b, d, f) on day 5 after
disease induction. C, glomerular capillary; P, podocyte; U, urinary space; V, vesicle. (g) Comparison of the number of immunogold particles
labeling for EB-labeled human serum albumin within the podocyte cytoplasm, podocyte vesicles, and on the surface of podocytes in
electron micrographs. A total of 30–50 images from kidney samples of three rats in each group were analyzed. **Po0.01 versus control.
zPo0.05, zzPo0.01 versus PAN. Bars¼ 500 nm (a, b) and 1 mm (c–f).
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Figure 7 |Renal handling of Evans Blue (EB)-labeled human serum albumin in green fluorescent protein (GFP) transgenic rats.
(a) Real-time confocal microscopic images of the renal tubules after injection of EB-labeled human serum albumin in puromycin
aminonucleoside (PAN) nephrotic GFP transgenic rats and their controls. EB fluorescence appeared immediately in the peritubular
capillaries (arrowheads), and later in the tubular lumen (indicated by asterisks) after 5min in PAN rats, but not in the control. (b) Confocal
microscopic images of glomeruli in vibratome sections. Podocytes uptaking EB-labeled human serum albumin turned yellow (arrowheads)
in PAN nephrotic rats, whereas podocytes without EB-labeled human serum albumin endocytosis showed GFP fluorescence in controls
(arrows). The degree of podocyte EB-labeled human serum albumin uptake was heterogenous among cells. Bar¼ 50 mm.
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intravenous injection of 0.5ml 4% human serum albumin bound to
EB at a 3:1 molecular ratio, real-time confocal images of
fluorescence for GFP (emission peak at 509 nm) and EB (emission
peak at 680 nm) were taken at 0, 1, 3, 5, 10, and 15mins. All images
for EB fluorescence were taken with excitation at 568 nm, laser
power at 20mW, and 1.56 s exposure time, whereas the settings for
all GFP fluorescence images were excitation at 488 nm, laser power
at 20mW, and exposure time for 599ms. A total of 30 images were
taken with 0.36 s intervals for each time point, and well-focused
images were chosen and overlayed to create the final image. After
15min, vibratome slices of the kidney were observed by confocal
microscopy to detect EB fluorescence in podocytes.
Measurement of urine and serum EB-labeled human
serum albumin, protein, and creatinine
Blood and urine samples were collected before and after bolus
injection of 2ml EB-labeled human serum albumin, using metabolic
cages. The concentration of EB-labeled human serum albumin was
measured by fluorescent spectrophotometry (Hitachi F-2000, Tokyo,
Japan) with excitation and emission wavelengths of 540 and 680 nm,
respectively. Protein and creatinine concentrations were measured
by spectrophotometry as described previously.44
Western blot for human serum albumin of isolated
glomeruli and SDS-PAGE of urine
After infusion of EB-labeled human serum albumin, 200 glomeruli
were isolated by graded sieving of the kidney and microdissection,
and western blotting was performed with rabbit anti-human serum
albumin antibody (Dako, Glostrup, Denmark) as the primary
antibody and HRP-conjugated anti-rabbit immunoglobulin
(Dako) as the secondary antibody, both at 1:400 dilution as
described previously.49 We also performed SDS-PAGE for urine
from five rats in each group. The area and density of bands for
albumin and IgG were measured using the NIH image software,
and urinary protein selectivity was evaluated by the urinary
IgG/albumin ratio.
Immunoprecipitation of glomerular proteins
with anti-FcRn antibody
The homogenate solution of 200 isolated glomeruli per rat was
incubated with protein A-sepharose for 30min to remove
nonspecific precipitation. After centrifugation at 15,000 r.p.m. for
5 s, the supernatant was incubated for 2 h at 4 1C with the addition
of a goat anti-FcRn antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) at 1:25 dilution and 10 ml protein A-sepharose. After
repeated washing by re-suspending in 4 1C lysis buffer and
centrifuging at 2000g for 2min, 20ml sample buffer was added.
Samples were subjected to SDS-PAGE, and western blotting was
performed with rabbit anti-human serum albumin antibody at 1:200
dilution, followed by HRP-conjugated secondary antibody at 1:200
dilution and 3,3’ diaminobenzidine staining.
Administration of anti-FcRn antibody to PAN
nephrotic rats
PAN nephrotic syndrome was induced in six male Sprague–Dawley
rats weighing 60–100 g, and in three rats, 200–400mg of anti-rat
FcRn antibody (Santa Cruz Biotechnology) was intraperitoneally
administered on the same day as PAN was induced. Urine was
collected for 8 h, and protein and creatinine concentrations
were measured, and SDS-PAGE of urine collected on day 5 after
PAN administration was performed. Subsequently, 1ml of
EB-labeled human serum albumin was intravenously injected,
and after 15min, kidneys were fixed with periodate-lysine-
paraformaldehyde solution and the sections were observed with a
confocal microscope.
Immunogold TEM and SEM
Immunogold TEM specimens were prepared as described pre-
viously.50 Briefly, ultrathin sections of Lowicryl blocks were
incubated with rabbit polyclonal antibody against human serum
albumin (Dako Glostrup) at 1:50 dilution, and then with 25-nm
gold-labeled goat anti-rabbit IgG antibody (Aurion, Wageningen,
the Netherlands) at 1:50 dilution for 4 h, and examined by
TEM (Hitachi H-7000). We counted the number of immunogold
particles observed within the podocyte cytoplasm and podocyte
vesicles in 30–50 micrographs from each group (magnification
 15,000).
For immunogold SEM, as described previously,51 periodate-
lysine-paraformaldehyde-fixed kidneys were cut by vibratome into
150-mm slices, and incubated with rabbit anti-human serum
albumin antibody as the primary antibody and 25 nm gold-labeled
goat anti-rabbit IgG antibody as the secondary antibody. After silver
enhancement (Aurion), samples were osmium coated at a thickness
of 5 nm with an osmium plasma coater (Filgen, Nagoya, Japan), and
observed by SEM (Hitachi S-4800) by backscattered electron
imaging. The number of gold particles within the podocyte
cytoplasm and podocyte vesicles, as well as on the surface of
podocytes, was compared at  15,000 magnification.
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Figure 8 |Role of FcRn as an albumin receptor in the
podocyte. (a) Immunoprecipitation analysis of isolated glomeruli
with anti-FcRn antibody. (b) SDS-PAGE of urinary protein from
puromycin aminonucleoside (PAN) nephrotic rats (n¼ 3) and PAN
nephrotic rats treated with antibody against rat FcRn (PANþ FcRn
Ab, n¼ 3) at day 5. (c) Amount of urinary protein per mg
creatinine. zPo0.05 versus PAN. (d) Confocal microscopic images
of glomeruli in Lowicryl sections after 15min of Evans Blue-
labeled human serum albumin. Podocytes are marked by
arrowheads. Bar¼ 50 mm.
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Cerium chloride histochemistry and urinary H2O2
measurement
We performed cerium chloride histochemistry by the methods of
Schlafer et al.52 Briefly, the abdominal aorta was cannulated, and
kidneys were perfused retrogradely for 10min with 100ml 1mmol/l
cerium chloride in imidazole-buffered physiological saline solution
(143mmol/l NaCl, 4mmol/l KCl, 25mmol/l NaHCO3, 1.2mmol/l
MgCl2, 2.4mmol/l CaCl2, 11mmol/l glucose; 37 1C, pH 7.4).
Kidneys were fixed with 2.5% glutaraldehyde and 2% paraformal-
dehyde in 0.01 M phosphate-buffered saline and embedded in epoxy
resin. Ultrathin sections were examined by TEM. Urinary H2O2 was
measured before PAN injection and at days 2 and 7 as described
previously.53
Pre-embedding immunoelectron microscopy for p47phox
To detect the NADPH oxidase component p47phox, pre-embedding
immunoelectron microscopy was performed as described
previously.54 Briefly, 50 mm vibratome sections were incubated
overnight with polyclonal anti-p47phox antibodies (Santa Cruz
Biotechnology) at 1:100 dilution, and then incubated for 1 h with
HRP-conjugated anti-rabbit IgG secondary antibody at 1:50
dilution. HRP signals were developed by 3,3’ diaminobenzidine,
and ultrathin sections were observed by TEM.
Statistics
All data are shown as mean±s.e.m. Mean values were compared
among groups using analysis of variance, followed, where
appropriate, by Fisher’s protected least significant difference test as
a post hoc test. P-values o0.05 were considered to be significant.
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